Seroconversion after recombinant Hepatitis B vaccination
Background: Hepatitis B virus infection is an important public health problem with significant morbidity and mortality. Recombinant hepatitis B vaccine for the prevention of hepatitis B virus infection is in practice in different parts of the world since its availability in 1986. Government of Bangl...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Bangladesh Society of Medicine
2010
|
Subjects: | |
Online Access: | http://irep.iium.edu.my/87312/1/Seroconversion%20after%20HBV%20vaccination.pdf http://irep.iium.edu.my/87312/ http://doi.org/10.3329/jom.v11i2.5461 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
my.iium.irep.87312 |
---|---|
record_format |
dspace |
spelling |
my.iium.irep.873122021-01-07T07:46:19Z http://irep.iium.edu.my/87312/ Seroconversion after recombinant Hepatitis B vaccination Guho, Abhijit Ahad, Md Abdul Salam, Md. Abdus Alim, Md Abdul Haque, A.K.M Enamul Islam, Quazi Tarikul QR180 Immunology Background: Hepatitis B virus infection is an important public health problem with significant morbidity and mortality. Recombinant hepatitis B vaccine for the prevention of hepatitis B virus infection is in practice in different parts of the world since its availability in 1986. Government of Bangladesh has also included hepatitis B vaccine in EPI schedule since 2005. Materials and methods: This study was carried out to assess the seroconversion status among hepatitis B vaccinated individuals. A total of 190 individuals including 150 vaccinated persons and 40 non-vaccinated apparently healthy individuals were included as study population. Sources of vaccinated persons were from both EPI and non-EPI schedule of vaccination. Age and sex matched non-vaccinated individuals served as controls for the study. All individuals constituting the study population were screened for HBsAg by Immunochromatographic strip test and only HBsAg-negative persons were included for estimation of their anti-HBs titer. Results: Out of 150 vaccinated individuals, 133(88.67%) were found to have anti-HBs titer in the protective level (>10 IU/L), while 17(11.33%) individuals had anti-HBs titer below the protective level (<10 IU/L). All non-vaccinated controls had anti-HBs titers below the protective level. Regarding immune response developed among vaccinated individuals, 67.78%, 23.33% and 8.89% were good-responders, hypo-responders and non-responders respectively. Mean titer of anti-HBs was found significantly higher among recipients who received booster dose than those who received 3 doses schedule (863.39 IU/L vs. 262.40 IU/L), indicating high antibody titer develops after booster dose. Vaccinated group included 85 (56.67%) men and 65 (43.33%) women with protective level of anti-HBs titer found in 85.88% male and 92.31% female individuals. There was no significant difference of anti-HBs titer between male and female (p>0.05). Vaccinated individuals from lower socioeconomic condition have had comparatively low rate of protective antibody than people from middle and upper classes. Conclusion: Recombinant HB vaccine induces good level of protective immunity among vaccinated persons. Bangladesh Society of Medicine 2010 Article PeerReviewed application/pdf en http://irep.iium.edu.my/87312/1/Seroconversion%20after%20HBV%20vaccination.pdf Guho, Abhijit and Ahad, Md Abdul and Salam, Md. Abdus and Alim, Md Abdul and Haque, A.K.M Enamul and Islam, Quazi Tarikul (2010) Seroconversion after recombinant Hepatitis B vaccination. Journal of Medicine, 11 (2). pp. 143-150. ISSN 1997-9797 E-ISSN 2075-5384 http://doi.org/10.3329/jom.v11i2.5461 doi:10.3329/jom.v11i2.5461 |
institution |
Universiti Islam Antarabangsa Malaysia |
building |
IIUM Library |
collection |
Institutional Repository |
continent |
Asia |
country |
Malaysia |
content_provider |
International Islamic University Malaysia |
content_source |
IIUM Repository (IREP) |
url_provider |
http://irep.iium.edu.my/ |
language |
English |
topic |
QR180 Immunology |
spellingShingle |
QR180 Immunology Guho, Abhijit Ahad, Md Abdul Salam, Md. Abdus Alim, Md Abdul Haque, A.K.M Enamul Islam, Quazi Tarikul Seroconversion after recombinant Hepatitis B vaccination |
description |
Background: Hepatitis B virus infection is an important public health problem with significant morbidity and mortality. Recombinant hepatitis B vaccine for the prevention of hepatitis B virus infection is in practice in different parts of the world since its availability in 1986. Government of Bangladesh has also included hepatitis B vaccine in EPI schedule since 2005. Materials and methods: This study was carried out to assess the seroconversion status among hepatitis B vaccinated individuals. A total of 190 individuals including 150 vaccinated persons and 40 non-vaccinated apparently healthy individuals were included as study population. Sources of vaccinated persons were from both EPI and non-EPI schedule of vaccination. Age and sex matched non-vaccinated individuals served as controls for the study. All individuals constituting the study population were screened for HBsAg by Immunochromatographic strip test and
only HBsAg-negative persons were included for estimation of their anti-HBs titer. Results: Out of 150 vaccinated individuals, 133(88.67%) were found to have anti-HBs titer in the protective level (>10 IU/L), while 17(11.33%) individuals had anti-HBs titer below the protective level (<10 IU/L). All non-vaccinated controls had anti-HBs titers below the protective level. Regarding immune response developed among vaccinated
individuals, 67.78%, 23.33% and 8.89% were good-responders, hypo-responders and non-responders respectively. Mean titer of anti-HBs was found significantly higher among recipients who received booster dose than those who received 3 doses schedule (863.39 IU/L vs. 262.40 IU/L), indicating high antibody titer develops after booster dose. Vaccinated group included 85 (56.67%) men and 65 (43.33%) women with protective level of anti-HBs titer found in 85.88% male and 92.31% female individuals. There was no significant difference of anti-HBs titer between male
and female (p>0.05). Vaccinated individuals from lower socioeconomic condition have had comparatively low rate of protective antibody than people from middle and upper classes. Conclusion: Recombinant HB vaccine induces good level of protective immunity among vaccinated persons. |
format |
Article |
author |
Guho, Abhijit Ahad, Md Abdul Salam, Md. Abdus Alim, Md Abdul Haque, A.K.M Enamul Islam, Quazi Tarikul |
author_facet |
Guho, Abhijit Ahad, Md Abdul Salam, Md. Abdus Alim, Md Abdul Haque, A.K.M Enamul Islam, Quazi Tarikul |
author_sort |
Guho, Abhijit |
title |
Seroconversion after recombinant Hepatitis B vaccination |
title_short |
Seroconversion after recombinant Hepatitis B vaccination |
title_full |
Seroconversion after recombinant Hepatitis B vaccination |
title_fullStr |
Seroconversion after recombinant Hepatitis B vaccination |
title_full_unstemmed |
Seroconversion after recombinant Hepatitis B vaccination |
title_sort |
seroconversion after recombinant hepatitis b vaccination |
publisher |
Bangladesh Society of Medicine |
publishDate |
2010 |
url |
http://irep.iium.edu.my/87312/1/Seroconversion%20after%20HBV%20vaccination.pdf http://irep.iium.edu.my/87312/ http://doi.org/10.3329/jom.v11i2.5461 |
_version_ |
1688547782518898688 |
score |
13.18916 |